Bioinformatics approaches identified dasatinib and bortezomib inhibit the activity of MCM7 protein as a potential treatment against human cancer
Crossref DOI link: https://doi.org/10.1038/s41598-022-05621-0
Published Online: 2022-01-27
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Samad, Abdus
Huq, Md. Amdadul
Rahman, Md. Shahedur
Text and Data Mining valid from 2022-01-27
Version of Record valid from 2022-01-27
Article History
Received: 23 July 2021
Accepted: 14 January 2022
First Online: 27 January 2022
Competing interests
: The authors declare no competing interests.